Hemex (Healthcare Services) Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series C1
- Latest Deal Amount
-
$7.7M
Hemex (Healthcare Services) General Information
Description
Developer of a clinical research and healthcare development platform designed to support medical technology organizations through clinical development. The company offers clinical trial management, regulatory support, patient recruitment, pharmacovigilance, medical writing, imaging services, and data management capabilities, enabling pharmaceutical, biotechnology, and medical device companies to manage clinical studies, maintain regulatory compliance, and accelerate healthcare product development workflows.
Contact Information
Website
www.hemex.chCorporate Office
- Kasernenstrasse 30
- 4410 Liestal
- Switzerland
Corporate Office
- Kasernenstrasse 30
- 4410 Liestal
- Switzerland
Hemex (Healthcare Services) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series C1) | 14-Feb-2022 | $7.7M | Completed | Generating Revenue | ||
| 1. Later Stage VC (Series B) | 01-Jan-2018 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Hemex (Healthcare Services) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hemex (Healthcare Services) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hemex (Healthcare Services) Investments (22)
Hemex (Healthcare Services)’s most recent deal was a Later Stage VC with Hemotune for . The deal was made on 01-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hemotune | 01-Dec-2025 | Later Stage VC | Therapeutic Devices | ||
| Annaida Technologies | 29-Apr-2025 | Later Stage VC | Other Devices and Supplies | ||
| Bottneuro | 15-Dec-2022 | Early Stage VC | Therapeutic Devices | ||
| Aspivix | 17-Nov-2022 | Later Stage VC | Therapeutic Devices | ||
| Hemotune | 26-Apr-2022 | Later Stage VC | Therapeutic Devices |
Hemex (Healthcare Services) FAQs
-
When was Hemex (Healthcare Services) founded?
Hemex (Healthcare Services) was founded in 2011.
-
Where is Hemex (Healthcare Services) headquartered?
Hemex (Healthcare Services) is headquartered in Liestal, Switzerland.
-
What is the size of Hemex (Healthcare Services)?
Hemex (Healthcare Services) has 21 total employees.
-
What industry is Hemex (Healthcare Services) in?
Hemex (Healthcare Services)’s primary industry is Other Healthcare Services.
-
Is Hemex (Healthcare Services) a private or public company?
Hemex (Healthcare Services) is a Private company.
-
What is Hemex (Healthcare Services)’s current revenue?
The current revenue for Hemex (Healthcare Services) is .
-
How much funding has Hemex (Healthcare Services) raised over time?
Hemex (Healthcare Services) has raised $7.7M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
